CEO calls Jabraenhance.com “very close to break-even,” but acknowledges that the target has been pushed back by several quarters.
✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this is a corporate financial update with no implications for clinical practice.
✦ Why It Matters ✦
Repeated delays in profitability for GN's direct-to-consumer online channel signal ongoing challenges in the OTC and e-commerce hearing aid market, which could influence how the sector invests in online sales models.
✦ Key Points ✦
- 01GN's CEO admits Jabraenhance.com is near break-even but not yet profitable.
- 02The profitability target has been pushed back by several quarters — not for the first time.
- 03The delay raises questions about the viability of GN's direct-to-consumer online hearing strategy.
- 04No product changes, recalls, or clinical updates are involved.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
Jabraenhance.com is near break-even but has not yet reached profitability.
quotepartially supportedGN has pushed back the profitability target for its online hearing business by several quarters.
quotesupported
